-
APPLIED DRIVING AND VISIONTRACK JOIN FORCES TO TARGET SAFER DRIVING - May 25, 2023
-
TRANSPORT EXCHANGE GROUP LAUNCHES INDUSTRY-FIRST ROAD TRANSPORT DATA SERVICE TO SUPPORT DYNAMIC FREIGHT PRICING - May 23, 2023
-
FDC HOLDINGS BOLSTERS FLEET TO MARK END OF SUCCESSFUL 25TH ANNIVERSARY CELEBRATIONS - May 22, 2023
-
The Dangers of Slip Injuries in the Workplace: Understanding the Risks and Taking Action - May 19, 2023
-
How Portable Storage Units Streamline Business Operations - May 19, 2023
-
High performance fashion logistics - May 19, 2023
-
CitrusAd gives brands the key to keywords - May 18, 2023
-
VISIONTRACK SUPPORTS GOODYEAR FIA EUROPEAN TRUCK RACING CHAMPIONSHIP WITH ADVANCED VIDEO TELEMATICS - May 17, 2023
-
LOGISTICS SPECIALIST FDC HOLDINGS ACQUIRES 330,000 SQ FT PRESTON HQ FROM HARWORTH - May 12, 2023
-
Logistics firm Gently unites with Cloud Paper in sustainable delivery partnership in Los Angeles - May 9, 2023
86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in the next 12 months
Investment in digital agility to improve operational resilience is the area where most work is needed
86% of pharma and biotech companies say they plan to become more digitally agile, according to a new survey of 100 senior pharmaceutical executives.
The survey, conducted by LogiPharma – the world’s leading annual conference covering pharmaceutical and medical device supply chains – asked global heads and directors of supply chain, logistics, procurement and IT how their organisations were upgrading their existing supply chain network to become more digitally agile.
Allowing logistics networks to be flexible and adapt to rapid changes and new innovations, including responding flexibly to geopolitical events and incorporating AI into networks were examples of how pharmaceutical and biotech companies say they will be enhancing their supply chains over the next year.
The number one challenge in building a digital supply chain was gaining visibility on the data and digital maturity roadmap, ensuring organisations can understand how digital transformation can help them recognise and plan for future challenges.
“One of the biggest focuses for our organisation has been utilising supply chain mapping solutions and embedding AI into that solution,” says Peter Stolba, Vice President, Business
Operations and Supply Chain, Trilink Biotechnologies.
“We have recently partnered with an external provider that has effectively mapped our tier one through to tier three suppliers. They have then overlaid AI to manage any risks that take place.
“Should any delays occur at a port, or airport, we are seeing real-time alerts and can respond sooner. Getting supplies has been incredibly difficult over the past two years and knowing immediately how to react to disruptions in the market has been essential.”
Learning from the pandemic
The global pandemic and geopolitical events such as the war in Ukraine have reinforced the need for operational resilience, particularly across global supply chains for vital products like pharmaceuticals.
Those surveyed said most work was needed in data management (22%), to improve the operational resilience, followed by temperature controls (21%) and investing in digital agility (18%).
61% felt that the most important factor for strengthening future supply chains was closer relationships with their suppliers to improve end-to-end visibility.
Peter Stolba adds:
“I think the pandemic has fueled the need for data visibility and the justification for investment into building a more robust digital supply chain. It is important that we leverage the information we have, and make key decisions based on our data points.”